Novel human hydroxylases and polynucleotides encoding the same

Details for Australian Patent Application No. 2002303879 (hide)

Owner Lexicon Pharmaceuticals, Inc.

Inventors Miranda, Maricar; Yu, Xuanchuan; Hu, Yi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002303879

PCT Number PCT/US02/16635

PCT Pub. Number WO2002/097039

Priority 60/294,076 29.05.01 US

Filing date 23 May 2002

Wipo publication date 9 December 2002

Acceptance publication date 9 August 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 9/04 (2006.01) Enzymes, e.g. ligases (6.) - acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/294,076 29.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002303879

9 August 2007 Application Accepted

  Published as AU-B-2002303879

9 August 2007 Change of Name(s) of Applicant(s), Section 104

  Lexicon Genetics Incorporated The name of the applicant has been changed to Lexicon Pharmaceuticals, Inc.

6 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303880-Tumor endothelial marker 7a molecules and uses thereof

2002303878-KINASES AND PHOSPHATASES